In recent years it has beenshown that cholinesterases of both types can catalyse the hydrolysis of many non-choline aliphatic esters (for literature see Whittaker, 1951) . The primary object of the present investigation was to find out if cholinesterases can also hydrolyse non-choline esters possessing an aromatic nucleus.
A series of p-substituted phenyl acetates was selected for study. It was found that these esters are indeed hydrolysed rapidly by the purified cholinesterases of human erythrocytes and plasma and by cobra-venom cholinesterase. During the course of the work it became apparent, however, that, as with aliphatic esters, the hydrolysis of the aromatic esters by whole human erythrocytes and plasma could be accounted for only in part by the cholinesterase content of these preparations. Some additional studies were therefore made of the other esterases involved.
The hydrolysis of aromatic esters by blood and tissues has been the subject of several previous studies, but little attempt has been made to characterize the enzymes responsible for hydrolysing them. The hydrolysis of short-chain aliphatic esters of p-nitrophenol (Huggins & Lapides, 1947; Huggins & Moulton, 1948) and of 2-naphthol Seligman, Nachlass & Mollomo, 1949) was attributed by these authors to aliphatic esterases (ali-esterases). Augustinsson (1948, 1950) studied the hydrolysis of acetylsalicylic acid, acetylsalicylylcholine and salicylylcholine by cholinesterase preparations derived from the blood, brain and tissues of various species, but no special precautions were taken to exclude other esterases. Zeller, Fleisher, McNaughton & Schweppe (1949) showed that preparations of snake venom and erythrocyte cholinesterase free from ali-esterase could hydrolyse phenyl acetate and p-nitrophenyl acetate, and that the hydrolysis was fully eserinesensitive, the latter constituting good evidence that the cholinesterase was responsible. Diluted whole human plasma, however, split phenyl acetate very much faster than acetylcholine and the hydrolysis was but little depressed by eserine, a result consistent with that of Huggins & Lapides (1947) with p-nitrophenyl acetate. The hydrolysis ofm-acetoxyphenyltrimethylammonium methosulphate by human serum and erythrocytes and rat brain was reported by Wescoe, Riker & Beach (1950) . Again, no precautions were taken to exclude non-choline esterases. Aldridge (1951a Aldridge ( , b, 1953 has studied the hydrolysis of p-nitrophenyl acetate, propionate and butyrate by the sera and tissues of a wide range of species. In addition to any contribution made by cholinesterase, two other enzymes, named by him the A-and B-esterases, present in varying proportions in different sera, hydrolyse these substrates.
The B-esterase, like the cholinesterases, is sensitive to toxic organophosphorus compounds; it hydrolyses butyrates faster than acetates. The A-esterase is not only insensitive to organophosphorus compounds; it has the remarkable property of hydrolysing at least one of them, diethyl p-nitrophenyl phosphate (E 600). The relation of these findings to our own work is discussed below.
MATERIALS AND METHODS
Substrates. Acetyl-fl-methylcholine (MCh; P-acetoxypropyltrimethylammonium chloride) and acetylcholine (ACh) were obtained commercially; they were used either without further purification or after conversion to the perchlorates (Bell & Carr, 1947) . Phenyl acetates were prepared from the corresponding phenol and acetic anhydride in the presence of aqueous NaOH (Chattaway, 1931 (B) Partially purifie preparation. Preparation A was brought to pH 5-9 and the precipitated stromata collected by centrifuging at 3000g. They were washed with water and 0-Im-pbosphate buffer, pH 6-1, until the supernatant was almost colourless. After a final wash with water they were resuspended in water, adsorbed on to kieselguhr and eluted * For definition of 'aceto-cholinestetase' see Sturge & Whittaker (1950) .
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with 0-2 % (w/v) NaHCO8 as previously described (Mounter & Whittaker, 1950) . QMch, 380; purification, yield, 53 %. This preparation hydrolysed tributyrin at less than 1% of the acetyl-.f-methylcholine rate and was therefore free from ali-esterase by the criteria adopted in the previous specificity studies of Mounter & Whittaker (1950) .
(C) Further-purified preparation. Preparation B was further purified as follows. The cholinesterase was collected by centrifuging at 16000g. for 30 min., dispersed in 0-2% (w/v) NaHCO3 and incubated for 12 hr. at 380 with lysolecithin (King & Dolan, 1933 Cobra-venom aceto-cholinesterase. The cholinesterase of cobra venom has recently been shown to be a typical acetocholinesterase (Mounter, 1951) , and it is unaccompanied by ali-esterase. The same sample of venom was used as in the earlier experiments without purification.
Butyro-cholinesterase. Human plasma was used as the source of butyro-cholinesterase. Experiments were carried out with (a) whole plasma, (b) a partially purified preparation free from ali-esterase, obtained by following Strelitz's (1944) Ammon (1933) with the precautions and controls described in previous publications (Sturge & Whittaker, 1950; Mounter, 1951 (Mounter, 1951 
RESULTS

Erythrocytes
The ability of human-erythrocyte cholinesterase to hydrolyse phenyl acetates was first studied with preparation B, which was free from ali-esterase (Table 1 ). It will be seen that phenyl acetate is split (Table 3) showed that a mixture of phenyl acetate and acetyl-,B-methylcholine was hydrolysed at a rate intermediate between those obtained with each substrate separately, thus suggesting that both substrates were competing for the same active centres. When inhibitor experiments were carried out, however, it was found that the hydrolysis of the phenyl acetates was not completely inhibited by concentrations of DFP and eserine which completely inhibited the acetyl-,-methylcholine hydrolysis (Table 1) . It was suspected, therefore, that part of the hydrolysis of the phenyl acetate by preparation Bwas due to an esterase which is distinct from both the cholinesterase and the aliphatic esterase and which had not been removed along with the latter during the purification procedure. We propose to refer to this esterase as the aromatic esterase. Studies were then continued with the more highly purified cholinesterase preparation (C). Table 2 shows the rate of hydrolysis of a number of p-substituted phenyl esters by this preparation. It will be seen that the rate of hydrolysis of phenyl acetate relative to acetyl-fl-methylcholine has dropped from 300 to 192 %, and the hydrolysis is completely or almost completely inhibited by concentrations of the three anti-cholinesterases, DFP, eserine and E 600 which are known to produce complete inhibition of cholinesterase activity. We believe, therefore, that the results in col. 2, Table 2, represent the rate at which these aromatic esters are hydrolysed by the red-cell cholinesterase relative to acetyl-,-methylcholine. It will be seen that all the esters are hydrolysed at appreciable rates, four faster than acetyl-f-methylcholine. p-Methoxyphenyl acetate is the most rapidly hydrolysed; phenyl acetate follows, and p-iodophenyl and pcresyl acetate are also split more rapidly than acetylf-methylcholine. The aromatic e8terase of erythrocyte.. Some properties of the aromatic esterase were studied using unpurified laked erythrocytes (preparation A). The earlier results ( Table 1 ) had indicated that this enzyme was relatively insensitive to DFP. This was confirmed in the experiments presented in Fig. 2 abolished by 1 blM-eserine as that due to the cholinesterase and the activity abolished by 1 iLM-DFP as that due to cholinesterase plus ali-esterase, the contribution made by the three esterases to the hydrolysis of each of the three substrates may be calculated. The results are presented in the form of block diagrams in Fig. 3 . The portion of the total phenyl acetate hydrolysis attributed to cholinesterase in this figure, when expressed as a percentage of the acetyl-f-methylcholine hydrolysis, gives a value identical with that obtained with purified cholinesterase (Table 2) It is interesting to note that about 16 % of the total phenyl acetate hydrolysis is attributed to the aliphatic esterase; since the total rate of hydrolysis of phenyl acetate is so much higher than that of tributyrin, phenyl acetate is actually split nearly three times as fast as tributyrin by this esterase. By contrast, the results with tributyrin show that this substrate is attacked at less than 1 % of the rate of phenyl acetate by the aromatic esterase. i8oAmyl acetate and n-hexyl acetate are also split by it at a negligible rate (Table 5 ).
The specificity of the aliphatic and aromatic esterases towards other phenyl acetates was next studied; the results are presented in Table 4 , and were obtained as follows. The aromatic esterase figures were obtained as before by measuring the rate of hydrolysis of the esters by lake cytes in the presence of 1 ,uM-DFP. The the aliphatic esterase were obtained by s from the DFP-sensitive portion of the t lysis the contribution made by the cho This was calculated from the specific obtained with preparation C (Table  known cholinesterase The presence of a second carboxylic estera-se in ity results an erythrocyte cholinesterase preparation, judged 2) and the enzymically homogeneous by previous criteria, reparation. raises the question as to whether the earlier specifid for com-city results of Adams & Whittaker (1948) , Adams (1949) and Mounter & Whittaker (1950) can be considered reliable. The relative rates of hydrolysis 4d aliphatic of i8oamyl acetate and n-hexyl acetate by the R aromatic esterase-free preparation C was therefore isof ester determined; the results (Table 5) The relevant results presented in Table 2 show no 192 evidence for the presence of an eserine-insensitive 157 aromatic esterase in the crude venom. The absence of ali-esterase has already been noted (Mounter, 1951) . results ob-All phenyl esters tested were hydrolysed at an o show that appreciable rate and the hydrolysis was inhibited substituted 97-100% by 10,uM-eserine, a concentration which surpassing inhibits the cholinesterase by the same amount ontrast, p- (Mounter, 1951) . The rates, relative to acetyl-Birable effect methylcholine, were 28-77 % lower than those though the obtained with the erythrocyte cholinesterase and natic esters there were two differences in the order in which the ad with that substrates were hydrolysed. The lower rate of hydrolysis may be related to the sharper aliphatic Lydrolysis of specificity already noted for this enzyme (Mounter, i three ery-1951 Partially purified butyro-cholinesterase (prepara. tion b) also hydrolysed these esters (Table 2) but at much lower rates relative to acetylcholine and the hydrolysis was now fully sensitive to 10 /Lm-eserine. Two other human-plasma butyro-cholinesterase preparations (c and d) of high purity hydrolysed the esters at essentially the same relative rates ( Myers & Mendel (1949) showed that human plasma contains an eserine-insensitive esterase which hydrolyses ethyl chloroacetate. The non-choline esterase has however been regarded as a minor constituent of human plasma in contrast to horse plasma which has a high 'ali-esterase' activity (for literature see Sturge & Whittaker, 1950) . The high rate of hydrolysis of certain aromatic esters, unaccounted for by the cholinQsterase content of the plasma, suggests that a second esterase distinct from the cholinesterase may, after all, be a major constituent of human plasma. It also raises the question as to the relation of the various non-choline esterase activities of plasma to the esterases of erythrocytes and to each other.
In an attempt to answer some of these points, we have studied the effect of DFP and eserine on the hydrolysis of phenyl acetate ini the same way as with laked erythrocytes. As will be seen in Fig. 4 the plasma: its inhibition closely paralleled that of acetylcholine, being negligible at an inhibitor concentration of 1 LM or more, and the tributyrin/ acetylcholine activity ratio (46 %) was equal to that of purified butyro-cholinesterase (Adams & Whittaker, 1949 In order to explore I three salient properties were selected for con sensitivity to E 600, optima and the pH of o terases of humah blood E 600 8enitivity. Fig. 5 shows that nitrophenol. as in Fig. 2 .
Triacetin was hydrolysed at about 15% of the faster than most aromatic phenyl acetate rate by erythrocyte aromatic )sterases are relatively in-esterase. Since tributyrin is hydrolysed at less than Our aromatic esterase some-1 % of the phenyl acetate rate, the acetate/butyrate -esterase recently described ratio for triglycerides must be greater than 15. This 1953) both in hydrolysing suggests that the aromatic esterase may after all eing insensitive to DFP; the have appreciable activity on some aliphatic esters. be related to the B-esterase There is evidence that the A-esterase can slowly xic organo-phosphorus com-hydrolyse ethyl esters (Aldridge, 1951 b) .
iof the ability ofthe A and B
The acetate/butyrate activity ratio for the 6liphatic substrates, but like aliphatic esterase of erythrocytes varied, being 3erine-insensitive. A further above unity for the phenyl esters and just less than that the A enzyme alone unity for glyceryl esters. It was, however, much a (Aldridge, 1953) .
lower than the ratios found with the aromatic these resemblances further, esterase. The B-esterases invariably had acetate/ 3 of the A-and B-esterases butyrate ratios well below unity for p-nitrophenyl aparison; their differential esters (Aldridge, 1951b (Aldridge, 1951 b). The optimum pH of the aromatic esterase was determined using plasma incubated with 1/LMeserine as the source of the enzyme and phenyl acetate as substrate. The reaction was carried out at different pH values in the presence of 0-05M-phosphate, and was followed by Hestrin's (1949) colorimetric method for carboxylic esters. As seen in Fig. 6 , the optimum pH lies close to 7-5. Three lines of evidence, insensitivity to E 600 and DFP, the acetate/butyrate ratio and the optimum pH thus suggest that our aromatic esterase and Aldridge's A-esterase are identical.
DISCUSSION
The ability of two aceto-cholinesterases and one butyro-cholinesterase to hydrolyse aromatic esters, as exemplified by a series of p-substituted phenyl acetates, has been demonstrated. The high rate of hydrolysis of these esters appears to be an exception to the general rule that the rate of hydrolysis of non-choline esters is determined by their degree of structural resemblance to the optimum choline ester. Exceptions to this rule have already been noted and discussed (Mounter & Whittaker, 1950; Whittaker, 1951) . The benzene ring is a highly polarizable structure and may be expected to confer an affinity upon these esters greater than that of structural analogues in the aliphatic series. Further, the non-enzymic rate of hydrolysis of all these compounds is higher than for simple aliphatic esters and this may be related to a greater instability of the enzyme-substrate complex.
Two other esterases have been found in human
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blood, but not in cobra venom, which also hydrolyse phenyl acetate. Both of these are insensitive to eserine but differ in their sensitivity to toxic organophosphorus compounds. One of them appears to be identical with the well known ali-esterase of human erythrocytes and hydrolyses all the esters except phenyl acetate less rapidly than tributyrin. This enzyme is absent from the plasma. The other esterase, here referred to as the aromatic esterase, is present in both erythrocytes and plasma and is characterized both by the low rate at which it attacks glyceryl esters and its high resistance to DFP and E 600. These properties, and the fact that it remained in an erythrocyte cholinesterase preparation which had been freed from ali-esterase, clearly distinguished it from the later enzyme. Proof of the identity of the plasma and erythrocyte aromatic esterases must await their isolation, but if not identical they are at any rate closely similar. Several lines of evidence suggest that the aromatic esterase is probably identical with the E 600-insensitive esterase recently described by Aldridge and named by him the A-esterase. In spite of its low rate ofhydrolysis ofaliphatic esters, its presence could probably account for all of the so-called aliphatic esterase activity of plasma. The aliesterase is less certainly but quite possibly to be identified with Aldridge's B-esterase. If this is true our concept of ali-esterase activity will have to be revised. The so-called ali-esterases may emerge as a group of relatively non-specific enzymes which are not limited to attacking aliphatic esters, or even, in the case of at least one member of the group, to carboxylic esters. The physiological role of these esterases remains obscure. It is possible, however, that they play a part in destroying hormones or drugs whose activity depends on an ester linkage and this possibility may prove relevant to our understanding of the mode of action of such substances.
SUMA:RY 1. The ability of two aceto-cholinesterases and one butyro-cholinesterase to catalyse the hydrolysis of a series ofp-substituted phenyl acetates has been demonstrated.
2. These esters are also attacked by an aromatic esterase present in human erythrocytes and plasma but not in cobra venom. 3. This enzyme attacks aliphatic esters slowly and is not affected by relatively high concentrations of dii8opropyl phosphorofluoridate or diethyl pnitrophenyl phosphate. It is probably identical with the recently described A-esterase.
4. The well-known ali-esterase of human erythrocytes also appears to hydrolyse the aromatic esters, but in general less rapidly than tributyrin. It can be separated from the aromatic esterase and is further distinguished from it by its sensitivity to toxic organophosphorus compounds. 5. Phenyl esters are thus hydrolysed by at least five esterases in human blood: erythrocyte acetocholinesterase, plasma butyro-cholinesterase, erythrocyte ali-esterase, erythrocyte aromatic esterase and plasma aromatic esterase. The last two enzymes are either identical or closely similar.
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